Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Bioprinting and Bioink Innovations for 3D-Tissues 2022

Dimitria Bonizol Camasao's Biography



Dimitria Bonizol Camasao, Senior Application Scientist, Rheolution

Dimitria B. Camasao is the senior scientist of Rheolution responsible for overseeing the life sciences applications team. She works closely with the users of Rheolution’s products to develop and customize protocols and methods, and to build value out of data they produce in their specific application. Dimitria holds a bachelor’s degree in Chemical engineering from the Universidade Estadual de Campinas (Brazil), a master and a PhD in Material Engineering from Université Laval (Canada). During her PhD, she worked on improving the mechanical properties of a blood vessel model using hydrogels, cells, and bioreactors. Dimitria brings over 7 years of research experience in hydrogels and polymers and has worked with multiple research groups worldwide in the field of life sciences.

Dimitria Bonizol Camasao Image

Analytical and AI Guided Design of Bioinks and 3D Bioprinted Scaffolds

Monday, 7 November 2022 at 10:00

Add to Calendar ▼2022-11-07 10:00:002022-11-07 11:00:00Europe/LondonAnalytical and AI Guided Design of Bioinks and 3D Bioprinted ScaffoldsBioprinting and Bioink Innovations for 3D-Tissues 2022 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

Formulating functional bioinks and optimizing 3D bioprinted scaffolds often involve time-consuming and costly trial and error approaches. The use of dedicated analytical testing instruments and artificial intelligence (AI) algorithms may significantly accelerate these tasks. In this presentation, we will first introduce the ElastoSensTM Bio, a nondestructive testing instrument that measures the viscoelasticity of soft biomaterials. We will highlight how its features can bring value to the 3D and 4D bioprinting process, from the formulation of bioinks to the design of bioprinted scaffolds and their time evolution with or without cells. We will then focus on two published cases to exemplify how this technology and AI are currently helping researchers. In the first work developed by a team from University of Victoria (BC), the ElastoSensTM Bio was used to understand how the architecture of a scaffold produced through an extrusion-based printing affected its viscoelastic properties in terms of fiber size, porosity, pore shape, and bioink composition. In the second work, the testing instrument was used to build and validate an AI model able to predict the polymerization kinetics of a synthetic photocrosslinkable hydrogel (PEGDA). These unique and novel methodologies have the potential to accelerate research in tissue engineering and regenerative medicine, and their translation into clinical practices.


Add to Calendar ▼2022-11-07 00:00:002022-11-08 00:00:00Europe/LondonBioprinting and Bioink Innovations for 3D-Tissues 2022Bioprinting and Bioink Innovations for 3D-Tissues 2022 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com